サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1498764

セラノスティクス市場：治療分野別、技術別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測

Theranostics Market, By Therapeutic Area, By Technology, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 325 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.02円
セラノスティクス市場：治療分野別、技術別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年06月04日
発行: AnalystView Market Insights
ページ情報: 英文 325 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

セラノスティクス市場規模は2023年に23億9,020万米ドルと評価され、2024年から2032年にかけて13.90%のCAGRで拡大

セラノスティクス市場- 市場力学

セラノスティクス市場を牽引する精密医療への注目の高まり

精密医療のアプローチは、腫瘍学、神経学、循環器学、感染症など、さまざまな医療分野で注目を集めています。データによると、2022年、精密医療による治療に費やされた総額は世界で約320億米ドルに達しました。2027年には、総支出は約1,240億米ドルに増加すると予測されています。ゲノミクス、プロテオミクス、その他のオミックス技術の進歩により、ヘルスケアプロバイダーは疾患の根底にある分子メカニズムをより深く理解し、治療効果を予測するバイオマーカーを特定することができます。例えば、肺がんのプレシジョン・メディシンの先進モデルであるセラノスティクスは、個々の患者の特性に対応するため、個別または対象となる集団の疾患の予防、診断、治療を組み合わせたものです。臨床的特徴に加え、肺がん患者のゲノム、トランスクリプトーム、プロテオーム、メタボローム特性を収集・統合することが必要となります。

セラノスティクス市場-主な洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024-2032年）に約13.90%のCAGRで毎年成長すると推定されます。

治療分野セグメンテーションに基づくと、腫瘍学が2023年に最大の市場シェアを示すと予測されました。

エンドユーザーセグメンテーションに基づくと、2023年には病院と診療所が主要タイプでした。

地域別では、北米が2023年に収益でリードしました。

セラノスティクス市場-セグメンテーション分析：

セラノスティクスの世界市場は、治療領域、技術、エンドユーザー、地域に基づいてセグメント化されます。

市場はエンドユーザーに基づいて3つのカテゴリーに分けられる：病院・クリニック、診断研究所、その他。疾患に関連する特定の分子標的を同定することにより、セラノスティックスは標的治療の提供を容易にします。このアプローチは治療の精度と有効性を高め、健康な組織への付随的なダメージを軽減します。多くのセラノスティック技術は、既存のヘルスケア・インフラにシームレスに統合できるため、多大なリソースやインフラを追加することなく、患者や臨床医が容易に利用できます。

市場は、治療領域に基づいて5つのカテゴリーに分類される：神経疾患、免疫疾患、循環器疾患、がん、その他の疾患です。肺がん、子宮頸がん、大腸がん、乳がん、その他のがんは、がん領域のセクションでさらに細分化されています。市場はがん領域がリードしており、予測期間中もリードし続けると予想されます。これは、セラノスティクスががん治療において、治療の遅れを軽減し、プロセスの多くの段階を省き、患者のケアを強化するために、より広く使用されるようになってきているためです。

セラノスティクス市場-地理的洞察

北米地域は、確立されたヘルスケアシステム、強力な研究機関、有利な規制枠組みにより、セラノスティクスの進歩をリードすることが多いです。特に米国は、セラノスティクスの開発と導入において複数の主要企業を擁しています。北米には、セラノスティクスの研究開発に積極的に取り組んでいる大手製薬企業が多数存在します。これらの企業は、セラノスティック製品の商業化を加速し、市場に投入するための資源と専門知識を有しています。中国、インド、韓国のような新興国は、医療インフラへの投資の増加、慢性疾患の有病率の上昇、精密医療の重視の高まりにより、セラノスティクスの急速な成長を目の当たりにしています。

セラノスティクス市場-競合情勢：

画像診断技術を専門とする企業も、セラノスティクス市場で競合しています。これらの企業は、疾患の診断やモニタリングに使用される画像薬剤や技術を開発しています。例えば、GEヘルスケア、シーメンス・ヘルティニアーズ、フィリップス・ヘルスケアなどが挙げられます。放射性医薬品企業は、セラノスティクスで使用される放射性医薬品の開発と生産に注力しています。これらの企業は、がんなど様々な疾患に対する標的療法を提供する上で重要な役割を果たしています。セラノスティクス市場では、製薬会社、診断会社、研究機関などさまざまな利害関係者の協力が一般的です。こうしたパートナーシップは、補完的な専門知識やリソースを活用することで、セラノスティック製品の開発と商業化を促進します。例えば、バイオメリューはグラクソ・スミスクラインと、臨床医が乳がん患者の異なるセグメントに対して最も適切な治療法を選択できるようにするための予測検査を開発する契約を締結しました。

目次

第1章 セラノスティクス市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 セラノスティクスの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 セラノスティクス産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 セラノスティクス市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 セラノスティクス市場情勢

  • セラノスティクス市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 セラノスティクス市場：治療分野別

  • 概要
    • 治療分野別セグメントシェア分析
    • オンコロジー
      • 乳がん
      • 肺がん
      • 大腸がん
      • 子宮頸がん
      • その他
    • 心血管疾患
    • 免疫疾患
    • 神経学的障害
    • その他

第8章 セラノスティクス市場：技術別

  • 概要
    • 技術別セグメントシェア分析
    • ポリメラーゼ連鎖反応（PCR）
    • 免疫組織化学（IHC）
    • シーケンシング
    • インサイチューハイブリダイゼーション（ISH）
    • その他

第9章 セラノスティクス市場：エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院と診療所
    • 診断ラボ
    • その他

第10章 セラノスティクス市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：セラノスティクス業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Thermo Fisher Scientific Inc.
    • AmeriPath, Inc.
    • Beckman Coulter, Inc.
    • Foundation Medicine, Inc.
    • Hoffmann-La Roche Ltd
    • Myriad Genetics, Inc.
    • Focus Diagnostics
    • Abbott Laboratories
    • Illumina, Inc.
    • QIAGEN
    • Agilent Technologies, Inc.
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Theranostics Market: Therupatic Area Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Therupatic Area
  • TABLE Global Theranostics Market, by Therupatic Area 2019-2032 (USD Million)
  • TABLE Theranostics Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Theranostics Market, by Technology 2019-2032 (USD Million)
  • TABLE Theranostics Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Theranostics Market, by End User 2019-2032 (USD Million)
  • TABLE Theranostics Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Theranostics Market, by Region 2019-2032 (USD Million)
  • TABLE North America Theranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Theranostics Market, by Therupatic Area, 2019-2032 (USD Million)
  • TABLE North America Theranostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE North America Theranostics Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Theranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Theranostics Market, by Therupatic Area, 2019-2032 (USD Million)
  • TABLE Europe Theranostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Europe Theranostics Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Theranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Theranostics Market, by Therupatic Area, 2019-2032 (USD Million)
  • TABLE Asia Pacific Theranostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Asia Pacific Theranostics Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Theranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Theranostics Market, by Therupatic Area, 2019-2032 (USD Million)
  • TABLE Latin America Theranostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Latin America Theranostics Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Theranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Theranostics Market, by Therupatic Area, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Theranostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Theranostics Market, by End User, 2019-2032 (USD Million)
目次
Product Code: ANV2935

REPORT HIGHLIGHT

Theranostics Market size was valued at USD 2,390.20 million in 2023, expanding at a CAGR of 13.90% from 2024 to 2032.

The theranostics market involves the combination of diagnostics with therapeutics to create personalized treatment plans for patients. This approach allows for tailored therapy based on an individual's specific genetic makeup, disease state, and other relevant factors. The key drivers of the theranostics market are the growing focus on personalized medicine and precision healthcare. By using diagnostic tests to identify biomarkers or specific molecular targets, healthcare providers can better match patients with the most effective treatments, potentially improving outcomes and reducing adverse effects. Furthermore, the increasing prevalence of chronic diseases, such as cancer and cardiovascular disorders, has fueled the demand for innovative therapeutic approaches.

Theranostics Market- Market Dynamics

Increasing focus on precision medicines propelling the theranostics market

Precision medicine approaches have gained traction across various medical fields, including oncology, neurology, cardiology, and infectious diseases. As per data, in 2022, total spending on treatments with precision medicine stood at some 32 billion U.S. dollars globally. By 2027, it is projected that total spending will increase to around 124 billion dollars. With advancements in genomics, proteomics, and other omics technologies, healthcare providers can better understand the molecular mechanisms underlying diseases and identify biomarkers that help predict treatment response. Forr instance, Theranostics, an advanced model of precision medicine for lung cancer, combines prevention, diagnosis, and treatment for individual or targeted population disorders to accommodate individual patient characteristics. In addition to clinical traits, it entails gathering and integrating lung cancer patient's genome, transcriptome, proteome, and metabolome properties.

Theranostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 13.90% over the forecast period (2024-2032)

Based on Therapeutic Area segmentation, oncology was predicted to show maximum market share in the year 2023

Based on end-user segmentation, Hospitals, and Clinics was the leading type in 2023

based on region, North America was the leading revenue generator in 2023

Theranostics Market- Segmentation Analysis:

The Global Theranostics Market is segmented on the basis of Therupatic Area, Technology, End User, and Region.

The market is divided into three categories based on end-users: Hospitals and Clinics, Diagnostic Laboratories, and Others. By identifying specific molecular targets associated with diseases, theranostics facilitates targeted therapy delivery. This approach enhances treatment precision, and effectiveness, and reduces collateral damage to healthy tissues. Many theranostic techniques can be seamlessly integrated into existing healthcare infrastructure, making them readily accessible to patients and clinicians without requiring significant additional resources or infrastructure.

The market is divided into five categories based on therapeutic area: Neurological conditions, immunological disorders, cardiovascular illnesses, oncology, and other conditions. Lung cancer, cervical cancer, colorectal cancer, breast cancer, and other cancers are further subdivided under the oncology section. The market was led by the oncology segment, which is anticipated to continue leading during the projection period. This is because theranostics is becoming more widely used in cancer therapy to reduce treatment delays, eliminate many steps in the process, and enhance patient care.

Theranostics Market- Geographical Insights

North America region often leads in theranostics advancements due to well-established healthcare systems, strong research institutions, and favorable regulatory frameworks. The United States, in particular, hosts several key players in theranostics development and adoption. North America is home to many leading pharmaceutical companies that are actively involved in theranostics research and development. These companies have the resources and expertise to accelerate the commercialization of theranostic products and bring them to market. Emerging economies like China, India, and South Korea are witnessing rapid growth in theranostics due to increasing investments in healthcare infrastructure, rising prevalence of chronic diseases, and a growing emphasis on precision medicine.

Theranostics Market- Competitive Landscape:

Companies specializing in diagnostic imaging technologies also compete in the theranostics market. They develop imaging agents and technologies used for the diagnosis and monitoring of diseases. Examples include GE Healthcare, Siemens Healthineers, and Philips Healthcare. Radiopharmaceutical companies focus on the development and production of radiopharmaceuticals used in theranostics. These companies play a crucial role in providing targeted therapies for various diseases such as cancer. Collaboration between different stakeholders such as pharmaceutical companies, diagnostic companies, and research institutions is common in the theranostics market. These partnerships facilitate the development and commercialization of theranostic products by leveraging complementary expertise and resources. For instance, bioMerieux has signed an agreement with GlaxoSmithKline to develop a predictive test to help clinicians select the most appropriate treatment for different segments of breast cancer patients.

Recent Developments:

In June 2023, The ICPO Foundation and FMRI recently revealed a reference center cooperation that will foster global standards of education in Radiomolecular Precision Oncology (RPO) and assist in setting up novel Theranostics Centres in India.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL THERANOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Thermo Fisher Scientific Inc.

AmeriPath, Inc.

Beckman Coulter, Inc.

Foundation Medicine, Inc.

Hoffmann-La Roche Ltd

Myriad Genetics, Inc.

Focus Diagnostics

Abbott Laboratories

Illumina, Inc.

QIAGEN

Agilent Technologies, Inc.

Others

GLOBAL THERANOSTICS MARKET, BY THERUPATIC AREA - MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Others
  • Cardiovascular Diseases
  • Immunological Disorders
  • Neurological Disorders
  • Others

GLOBAL THERANOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry (IHC)
  • Sequencing
  • In Situ Hybridization (ISH)
  • Others

GLOBAL THERANOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Others

GLOBAL THERANOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Theranostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Theranostics Market Snippet by Therupatic Area
    • 2.1.2. Theranostics Market Snippet by Technology
    • 2.1.3. Theranostics Market Snippet by End User
    • 2.1.4. Theranostics Market Snippet by Country
    • 2.1.5. Theranostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Theranostics Key Market Trends

  • 3.1. Theranostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Theranostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Theranostics Market Opportunities
  • 3.4. Theranostics Market Future Trends

4. Theranostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Theranostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Theranostics Market Landscape

  • 6.1. Theranostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Theranostics Market - By Therupatic Area

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Therupatic Area, 2023 & 2032 (%)
    • 7.1.2. Oncology
      • 7.1.2.1. Breast Cancer
      • 7.1.2.2. Lung Cancer
      • 7.1.2.3. Colorectal Cancer
      • 7.1.2.4. Cervical Cancer
      • 7.1.2.5. Others
    • 7.1.3. Cardiovascular Diseases
    • 7.1.4. Immunological Disorders
    • 7.1.5. Neurological Disorders
    • 7.1.6. Others

8. Theranostics Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 8.1.2. Polymerase Chain Reaction (PCR)
    • 8.1.3. Immunohistochemistry (IHC)
    • 8.1.4. Sequencing
    • 8.1.5. In Situ Hybridization (ISH)
    • 8.1.6. Others

9. Theranostics Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Hospitals and Clinics
    • 9.1.3. Diagnostic Laboratories
    • 9.1.4. Others

10. Theranostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Theranostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Theranostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Theranostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Theranostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Theranostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Theranostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific Inc.
    • 11.2.2. AmeriPath, Inc.
    • 11.2.3. Beckman Coulter, Inc.
    • 11.2.4. Foundation Medicine, Inc.
    • 11.2.5. Hoffmann-La Roche Ltd
    • 11.2.6. Myriad Genetics, Inc.
    • 11.2.7. Focus Diagnostics
    • 11.2.8. Abbott Laboratories
    • 11.2.9. Illumina, Inc.
    • 11.2.10. QIAGEN
    • 11.2.11. Agilent Technologies, Inc.
    • 11.2.12. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us